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ABSTRACT 
Gestational diabetes is a metabolic disorder characterized by carbohydrate intolerance first 
during pregnancy associated with foetal and maternal complications. The aim of the study is 
to assess the pregnancy outcome as influenced by dietary versus insulin management among 
GDM mothers. A total of 102 pregnant women, visiting the antenatal clinic of Apollo 
Hospitals, Bangalore were recruited for the study, classified as control and GDM groups 
based on the blood glucose levels using IADPSG guidelines, each group consisted of 
51subjects. GDM group was further classified as diet managed group (n=23) and insulin 
managed group (n=28) depending on the modes of management.  Biochemical profile was 
analyzed and recorded in both groups. Non-significantly higher term weight and a lower 
gestation week of delivery (37 ±1.51 weeks) and significantly higher HbA1c (6.5±1.02%) 
was observed in the insulin managed group when compared to the diet managed group, while, 
total cholesterol and triglyceride levels were significantly higher in the diet managed group 
(p<0.03 and 0.007) respectively.  Caesarean section was common in both groups.  The mean 
birth weight of the infants in both groups was comparable (2.9±0.3 and 2.8±0.52 kg). 
Whereas, significantly higher serum bilirubin levels were observed in infants born to insulin 
managed women (9 ±4.78 mg/dl), indicating a poor morbidity status in these infants. Medical 
nutrition therapy and insulin initiation are the two modes of blood glucose management in 
GDMs which aids in preventing complications and influencing near to normal pregnancy 
outcome. 
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INTRODUCTION 
“Gestational Diabetes is defined as any degree of glucose intolerance with onset or first 
recognition during the pregnancy”. In pregnancy insulin sensitivity decreases, pregnant 
females are at greater risk to have deranged blood glucose levels and subsequently some of 
them develop gestational diabetes mellitus (GDM).Gestational diabetes mellitus is a common 
disorder affecting 1-14 % of all pregnancies
1
.When GDM is left untreated, hyperglcaemic 
blood is carried to the foetus through placenta, leading to foetal hyper-insulinemia. This 
increased endogenous insulin acts as growth factors for foetus leading to storage of excessive 
amounts of glucose as glycogen and fat in the foetal body, making these babies larger than 
the normal. In large sized foetus oxygen demand increases causing hypoxic condition in 
utero, leading to structural and functional alterations in the placenta
2
. This affects the normal 
mechanism of functioning in human placenta with complex vascular system.  Adequate 
growth and maturity of foeto-placental vessels are important for normal fetal growth and 
survival
3
. Complications of GDM encountered in foetus are increased birth weight, birth 
trauma, respiratory distress syndrome (RDS), hypoglycaemia, hyperbilirubinemia, 
polycythemia, hypocalcemia, major congenital anomalies, intrauterine deaths at term and 
even still births where as in mother there are more chances of excessive weight gain, pre-
eclampsia, caesarean sections and development of Type 2 diabetes in subsequent years
4
. 
Blood glucose levels in the mother can be controlled by diet control and exercise, when diet 
control fails to maintain target glycaemic levels, insulin is initiated. Insulin is the traditional 
therapy and gold standard under such circumstances
5
. Despite these interventions like 
pharmacotherapy, foetal and maternal morbidity and mortality are well documented in the 
literature
6
. Therefore, there are different modes of managing blood glucose levels in GDMs.  
These modes of management might be helpful in explaining the adverse foetal and maternal 
outcomes in gestational diabetes. With this background present study was designed to 
observe the effect of diet and insulin management on foetal and maternal outcomes in 
gestational diabetics. 
MATERIALS AND METHOD 
Study design 
 A case-control descriptive and analytical study, conducted between July 2012 to July 2014 in 
Bangalore district of Karnataka.   
Study site 
Subjects were recruited from the antenatal clinic of Apollo Hospital, a multispecialty hospital 
from urban part of the district between the age group 20-39 years.   This study was carried 
out after obtaining the ethics committee approval in Apollo Hospital, Bangalore and in 
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University of Mysore, Mysore.  A total of 102 pregnant women were included for the study 
based on the willingness to participate by obtaining an informed consent. A pretested 
questionnaire was used to interview the subjects to elicit information for data collection. 
After recruiting the subjects for the study, pre-pregnancy anthropometric measurements, 
height and weight was recorded as self reported by the subjects and also from the medical 
records.  Body mass index (BMI; Weight in kilograms divided by the square of the height in 
meters) was calculated using the pre-pregnancy anthropometry
7
. 
Subjects were classified as control and GDM groups based on the blood glucose levels using 
IADPSG guidelines
8
, each group consisted of 51subjects. The GDM group was further 
classified as diet managed group (n=23) and insulin managed group (n=28) depending on the 
modes of management.  Biochemical profile was analysed and recorded in both groups. 
Data collection 
Data regarding the subjects' background characteristics, personal and family medical history, 
lifestyle habits and behaviours, and course of pregnancy were collected by face-to-face 
interviews. The collected data included details like age, occupational status, education level, 
socio economic status, family history of co-morbidities, morbidity status of the subject, 
Gynaecology history, previous pregnancy complications, 24 hr dietary recall during 
pregnancy and physical activity levels. 
Dietary recall 
Dietary data was collected and analyzed using a 24 –hour diet recall questionnaire.  Subjects 
were asked to recall foods taken over the past 24 hours using household measures relevant to 
Indian cuisine (serving bowls of various sizes, spoons or ladles) to assess the portion size. 
These food items were further converted to the raw food items and nutritive value was 
calculated.  Data collected included information on current food frequency, dietary pattern 
and food habits. The data from 24hr recall were analyzed and nutritive value was calculated 
using the Indian food composition tables
9
. The regularity of intake and distribution of caloric 
and carbohydrate intake among meals and snacks throughout the day were determined.   
Nutrient recommendations for each individual was calculated considering the pre-pregnancy 
weight (underweight, normal, overweight, or obese) and amount of weight gain during 
pregnancy (within normal range or excessive) according to the recommended dietary intake 
(RDI) using Indian food composition tables
9 
. 
 The carbohydrate: protein: fat ratio was calculated according to the ICMR guidelines for 
pregnancy in the control group and GDM women as 50: 30: 20, 50% of the total calories 
from carbohydrates (more of complex carbohydrates), 30% of the total calories from fat and 
20% of the total calories from protein
10
. Moreover, additional energy intake during pregnancy 
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is a major requirement to meet up the increasing demands of pregnancy and the increase in 
BMR, since, reduction in physical activity did not compensate for the maternal and foetal 
energy requirements
11
. 
Physical activity levels assessment 
Physical activity levels were assessed in each group by filling a questionnaire, energy cost of 
activity was calculated
12
. The time spent on each group of activities was then multiplied by 
the energy cost of that activity (kcal/ kg body weight/hour).  The energy cost of physical 
activities in a day was then totaled up.  To adhere to the normal practices of presenting the 
energy cost of physical activities per day, the average of three consecutive days was 
calculated and the data was utilized for the study.  Physical activity level and energy 
expenditure calculation was done using the WHO/FAO/UNU equation.  
Statistical analysis 
Data was analysed using SPSS statistics version 16.0.  Mean and standard deviation were 
calculated for data pertaining to socio-demography, anthropometry, dietary intake and energy 
expenditure using t- test statistical significance testing between the two groups.  The level of 
significance was set at p<0.05 for all analyses (two tailed). 
RESULTS AND DISCUSSION 
A total of 102 pregnant women were recruited for the study, 51 subjects were control subjects 
and 51 were Gestational diabetics in the study, these subjects were drawn from Apollo 
Hospital, Bangalore.  
Socio demographic characteristics of study population:  
 As shown in Table 1, the mean age of GDM women and control group was 29.05 y ± 3.55 
and 28.49 y ± 3.54, BMI was 25.58 kg/m
2
 and 24.0 kg/m
2
 respectively.  Comparison of pre 
pregnancy weight among the subjects revealed that the control group had a higher percentage 
of women with normal body weight 37.25%, overweight subjects were also higher in the 
control group 27.4%, whereas, a higher percentage of women in obesity category Grade I and 
II were observed in GDM women 47.1%. Though a difference was observed between the two 
groups, it was statistically not significant (p= 0.570).  Therefore, it is crucial to attain 
adequate pre-pregnancy weight and appropriate weight gain to experience normal course of 
pregnancy and reduce the risk of complications associated with pregnancy outcome. Majority 
of women in the GDM group 62.7%  had family history of type 2 diabetes was when 
compared with the control group, this difference was statistically significant (p< 0.05), 
indicating that presence of family history of Type 2 diabetes is one of the  contributing risk 
factors for the onset of gestational diabetes. Occupational status of the subjects did not have a 
significant contribution (p>0.05), for the onset of gestational diabetes.   
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Table 1: Descriptive socio-demographic characteristics of the subjects (n=102) 
 GDM women 
n=51 
Mean(±SD) 
Control subjects 
n=51 
Mean(±SD) 
p value 
Age (yrs) 29.05(±3.55) 28.49(±3.54) 0.420 
Height(cms) 157.4(±6.77) 159.1(±5.66) 0.186 
Weight (kgs) 63.41(±9.84) 60.75(±8.65) 0.150 
BMI (kg/m
2
) 25.58 (±3.50) 24.02 (±3.18) 0.019* 
 Mean n (%) Mean n (%) 
Underweight  2(3.92%)  
Normal 13(25.5%) 19(37.25%) 0.057 
Overweight 8(15.7%) 14(27.4%) 
Obesity Grade I 24(47.1%) 14(27.4%) 
Obesity Grade II 6(11.76%) 2(3.92%) 
Family history of Diabetes 32(62.7%) 20(39.2%) 0.017* 
Employed                                  29(56.9%)             29(56.9%)    
Home makers 22(43.1%) 22(43.1%) 1.000 
*Statistically significant  
Table 2, depicts that nutrient consumption of control group was better than GDM group 
subjects, the difference in energy and CHO intake was statistically significant. 
Table 2: Comparison of nutrients intake between the two groups 
Nutrient Intake GDM Women Control Group p value 
Mean  ±SD 
Intake 
Mean  ±SD 
Intake   
Energy(kcals) 1844(±304) 1968(±297.61) 0.04* 
Protein(gms) 57 (±11) 58(±8.50) 0.800 
Fat(gms) 67.50(±17) 69(±16) 0.746 
CHO(gms) 239(±46) 265(±36) 0.002* 
RDI-Recommended Dietary Intake, GDM- Gestational Diabetes Mellitus  
*Statistically significant p<0.05 
Time allocation and energy expenditure was calculated for activities like household work, 
personnel work, commuting, office work, recreation, rest & sleep and child care and 
compared between the groups.  The findings of the study demonstrated that the time 
allocation and energy expenditure was significantly different between the two groups (p < 
0.05) for child care.   
Biochemical parameters were compared between both groups, blood glucose levels of the 
subjects were managed with diet control and insulin therapy.  Diet control consisted of 
carbohydrate restrictions, initiation of complex carbohydrate, small and frequent meals and 
high fibre intake on a daily basis. When medical nutrition therapy failed to control blood 
glucose levels, insulin therapy was initiated, which involves administration of insulin 
injections as prescribed, which varies depending on the glycaemic control in the subjects. 
Insulin therapy increases the risk of maternal hypoglycaemia leading to adverse pregnancy  
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outcome.  
Initially, a very low dosage of short acting insulin such as human actrapid was started, later, 
the dosage was adjusted based on the glycaemic control.  Additionally, a combination of 
short acting and long acting insulin was prescribed. However, it was observed that the dosage 
of insulin was increasing with the progression in pregnancy.  In this study, women were 
prescribed with insulin formulations such as human actrapid, insulatard, lispro, levemir etc., 
the dosage was ranging between 4 units to 40 units maximum in these subjects. 
In table 3, blood glucose levels of diet and insulin managed GDM subjects are reported, in 
fasting and postprandial conditions in the third trimester at different time points, 28-32, 33-
36, 37-41 weeks of gestation.  The observed values reveal that FBS and PPBS values were 
exceeding the desirable range of blood glucose levels in both groups, and  were in the 
comparable range.  This was probably due to the regular follow-up of GDM women in the 
antenatal clinic of the hospital and the impact of personalised diet chart they received, that  
controlled calories and  carbohydrate consumption.  The difference in the blood glucose 
levels (FBS& PPBS) was significantly different at different time points in this study (F= 
4.267 and F=21.53).  This table also depicts the HbA1c levels of GDM subjects, which is 
significantly different between the different time points.   
Table 4, reveals that there was a significant difference in the birth weights of infants born to 
Control group subjects, diet and insulin managed GDM group subjects.  Gestation week was 
significantly lower in the insulin managed group (p<0.05), chest circumference (33.17cm) 
was significantly higher than the diet managed group (p<0.05). The other anthropometric 
parameters such as weight and HC was higher in the diet managed group (2.92cm) and 
(33.52cm) respectively.  Diet managed group had taller babies compared with the insulin 
treated group (48.80 cm). However, total cholesterol (214±47.7mg/dl) and triglyceride levels 
(220±11.9mg/dl) were significantly higher in the diet managed group compared to insulin 
managed groups (p<0.03 and 0.007) respectively, while HbA1c (6.5%) was found to be 
higher in the insulin managed group.  The difference was statistically significant only for the 
difference in CC in the infants born to these subjects.   Although, there was a difference 
between the subgroups, for parameters such as HC, CHL, BMI and BSA, it was statistically 
not significant, indicating that the birth parameters were in the comparable range in the 
subgroups.  Therefore, when MNT fails to control blood glucose levels, insulin is the last and 
reliable option for reducing the adverse pregnancy outcome.   
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Table 3: Biochemical parameters of diet and insulin managed GDM Subjects (mean±SD) 
Group Blood Glucose levels(mg/dl)(n= 51) 
28-32 weeks 33-36 weeks 37-41 weeks F value (p value) 
 FBS PPBS FBS PPBS FBS PPBS  
Mean±SD 
Haemoglobin(Hb) 11.77±1.42 11.6±1.30 11.6±1.16 0.477NS 
HbA1c(g/dl) 6.12±0.87
@
 6.00±0.57
&
 5.7±0.48 11.56* 
Diet managed(mg/dl)n=23 110±36.2 143±37.3 133±11.60 152±22.47 130±15.3 156±23.04 4.167*(0.020) 
Insulin Managed(mg/dl) n=28 123±70.0 147±23.9 133±25.5 149±27.5 128±23.7 161±23.18 21.53*(0.001) 
 FBS-Fasting Blood sugars, PPBS- Post Prandial Blood Sugars 
 HbA1c- glycosylated haemoglobin, @HbA1C at 28weeks and &HbA1C 32 weeks differ significantly from the HbA1C of 36 weeks 
 *Significant at 5% level 
 NS- Non Significant 
Table 4: Neonatal birth parameters of infants born to diet and insulin managed group subjects in GDMs 
 Gestation weeks Birth weight 
kg 
HC 
cm 
CC 
cm 
CHL 
cm 
BMI 
kg/m
2 
BSA 
m
2 
Serum Bilirubin 
mg/dl 
HbA1C 
g% 
Control(n=45) 37.71±1.32 2.87±0.42 33.84±2.07 31.76±2.78 47.58±3.48 12.8±2.54 0.17±0.7 7.12±3.98 NA 
Diet(n=30) 38.1±1.1 2.9±0.3 33.07±1.03 32.50±0.51 48.35±3.5 12.3±2.1 0.20±0.02 7.2±3.2 6.0±0.5 
Insulin(n=23) 37.1±1.51 2.8±0.52 32.88±2.5 33.17±0.6 48.20±2.6 11.9±1.7 0.19±0.02 9.0±4.78 6.5±1.02 
t value 2.64 * 0.81NS 0.488 NS 3.82* 0.17 NS 1.82 NS 1.80 NS 1.53 * 2.00 * 
p value 0.01 0.42 0.7 0.00 0.15 0.07 0.07 0.049 0.005 
*Significant at 5% level 
NS – Non significant 
NA –Not Applicable 
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The present study aimed to investigate pregnancy outcome as influenced by dietary 
management versus insulin treatment among GDM mothers.  Obese and overweight women 
are at a greater risk for the onset of gestational diabetes and presence of family history of 
Type 2 Diabetes increases the risk by multiple folds.  To ensure a better outcome of 
pregnancy it is important to maintain normal body weight before pregnancy
13
.  Maternal 
obesity is also known to increase the risk of childhood obesity and diabetes in the off springs 
1
.   It is also important to have adequate gestational weight gain which has substantial impact 
on maternal health and would lead to better obstetric management
14
.  It is also reported that 
pre pregnancy weight management decreases the risk of gestational diabetes in women
15
. 
This study demonstrates that increase in age is not always directly proportional to the onset of 
gestational diabetes, while, >30 years the risk of gestational diabetes is higher
16
. Family 
history of diabetes is the predisposing factor for the onset of Gestational Diabetes
17
. 
However, presence of family history of type 2 diabetes increases the risk of GDM by three 
folds 
18
. 
Maternal food intake during pregnancy, particularly, in the second trimester was associated 
with a risk of abnormal glucose metabolism later in pregnancy
19
.  Macronutrient intake was 
found to be higher in the control group than GDM women, indicating that control group 
subjects had better food intake than GDM women. The difference in energy intake and 
expenditure was significant and was indicating a negative energy balance among these 
subjects.  This observation could be due to a greater percentage of subjects were from a 
higher educational background with adequate information and awareness about the additional 
nutrition requirements during pregnancy
20
. 
This study demonstrates that women are more sedentary during pregnancy and do not have 
schedule for physical activity, this observation is similar to the study that states there is 
decrease in the intensity of physical activity and preferred more sedentary activities like 
household activities, recreation, rest and sleep 
21
. 
Biochemical parameters reflect these adaptive changes and are totally different from the non-
pregnant state. The woman's renal function, carbohydrate and protein metabolism, and 
particularly the hormonal pattern are affected. It is critical to appreciate both normal and 
abnormal changes as laboratory results can influence the management of both mother and 
child 
22
.  Pregnancy is characterized by a progressive increase in nutrient-stimulated insulin 
responses despite an only minor deterioration in glucose tolerance, consistent with 
progressive insulin resistance. 
 Changes in carbohydrate and lipid metabolism occur during pregnancy to ensure a 
continuous supply of nutrients to the growing foetus despite intermittent maternal food 
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intake. These metabolic changes are progressive and may be accentuated in women who 
develop gestational diabetes mellitus 
23
.  
During early pregnancy there is an increase in body fat accumulation, associated with both 
hyperplasia and increased lipogenesis because maternal cholesterol is the source of 
cholesterol for the foetus during early gestation, which reduces during late pregnancy due to 
the capacity of foetal tissues to synthesize cholesterol. Maternal hypertriglyceridemia is also 
a characteristic feature during pregnancy and leads to an accumulation of triglycerides. 
Triglycerides do not cross the placental barrier 
24
. This suggests there is a rise in serum lipid 
levels during pregnancy.  The occurrence of altered serum lipid profile was seen in the GDM 
group women.  In the present study, it was found that serum triglycerides were significantly 
different between the two groups.  
It is very interesting to note that even the control group subjects had elevated TC, TG and 
LDL levels similar to the GDM group, except that the number of subjects was lesser than 
GDM women.  Moreover, TC and TG levels were found to be higher in the diet managed 
group than the insulin managed group. 
Foetal macrosomia is commonly associated with gestational diabetes mellitus (GDM) which 
may lead to various complications.  A better control and regulation of serum lipids along with 
glycaemic control may prevent the occurrence of foetal macrosomia.   In GDMs  fasting and 
post prandial blood sugar levels with HbA1c is monitored at regular intervals to control blood 
glucose levels for better outcome of pregnancy.   
The HbA1c level is proportional to average blood glucose concentration over the previous 
four weeks to three months. HbA1c assay cannot be used as a single marker to diagnose 
gestational diabetes; it is a low predictive value to diagnose gestational diabetes 26.  Fong et 
al. found that women with HbA1c of 5.7-6.4 % at first prenatal visit (up to 20 weeks of 
gestation) had a 3-fold higher risk of developing GDM compared to those with HbA1c < 5.7 
% 27.   
During pregnancy an increase in plasma volume causes hemodilution resulting in a lowering 
of the haemoglobin (Hb) to approximately 11.5 g/dl 
28
.   In the present study, Hemoglobin 
levels were recorded to be almost similar in all the trimesters, it from 11.6 to 11.77mg/dl.  A 
significant difference in the Hb levels were not reported between the trimesters.  
GDM women were subjected to regular blood glucose monitoring using a glucometer was 
designed to cover fasting and postprandial blood sugars in a day.  It is observed that there was 
a significant difference in the blood glucose levels between trimesters in these two groups.  
Blood glucose management was through diet control initially, subsequently, insulin therapy 
was initaited.   Therefore, results of the study confirm that the GDM subjects were visiting 
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the ANC and were compliant with the dietary modifications prescribed by the Dietitian.    It 
also suggests that initiation of insulin therapy when fasting blood glucose is >95 mg/dl with 
dietary modifications may achieve lower rates of macrosomia
29
.   However, prophylactic 
insulin therapy was not advised in subjects with rigid glycaemic control.  Patients on insulin 
therapy have lower rate of complications when compared with diet managed subjects despite 
achieving the same glycaemic goals. This implies that other factors may be associated with 
the pathogenesis of adverse outcomes in GDM 
30.
 
CONCLUSION 
Comparison of diet versus insulin management on pregnancy outcome among GDM group 
revealed that subjects in the insulin managed group reported lower gestation week at delivery 
and higher HbA1c levels than the diet managed group. Moreover, significantly higher total 
cholesterol and triglyceride levels were demonstrated in diet managed group. Therefore, it 
indicates that the diet managed group subjects were liberal in food consumption and ignorant 
about the complications that can occur during pregnancy, especially, when diagnosed as 
gestational diabetic.  It was also observed that serum bilirubin levels were higher in the 
infants born to insulin managed group, indicative of a poor morbidity status.  This might be 
the adverse impact of high blood sugar levels requiring insulin therapy.   
The neonatal parameters of the infants born to diet managed and insulin managed groups 
indicates that outcome of pregnancy between the two groups of infants was in the comparable 
range, thus, insulin intervention has positively influenced the outcome of pregnancy among 
GDM subjects.   
Overall, gestation performance and birth outcomes are interdependent factors that influence 
the outcome of pregnancy to a greater extent.  Therefore, these factors are termed as crucial 
components for pregnancy outcome, which require intense monitoring, whereas, in this study 
mode of blood glucose management also has been found to have an impact on pregnancy 
outcome.  Furthermore, the recommendations to the clinicians is to  maintain tight glycaemic 
control in GDM subjects by initiating the recommended modes of blood glucose management 
to facilitate normal pregnancy outcome. 
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